Counterfeit Version of Avastin In U.S. Distribution

The FDA announced a warning to healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States.

The counterfeit version is labeled as Avastin, manufactured by Roche and does not contain the medicine's active ingredient, bevacizumab, which my have resulted in patients not receiving needed therapy. 

Avastin is an injectable medicine used to treat various types of cancer, including brain cancer, and is administered to patients in clinics, hospitals, and doctors' offices.

Click here for FDA announcement.

 

Share |
April 15, 2015 10:01 AM
We welcome the newest member of our team. Kathleen brings a wealth of major and corporate gift development experience.
March 30, 2015 05:33 PM
ABC2 was an early investor in this pioneering research.
March 19, 2015 09:35 PM
Proceeds from the Florida Brain Cancer 5k support this ongoing partnership.

Join us in our fight for a cure!

Twitter